Based on these collective results, we hypothesized that over-activation of RhoA might contribute to the pathogenesis of TRPV4 neuropathy, and that inhibition of RhoA could potentially rescue mutant TRPV4-mediated neuronal degeneration. Here, RHOA is linked to neuropathy.